Shares of Universe Pharmaceuticals INC (NYSE:UPC – Get Free Report) shot up 10.5% on Friday . The company traded as high as $4.30 and last traded at $4.20. 264,461 shares traded hands during trading, an increase of 118% from the average session volume of 121,452 shares. The stock had previously closed at $3.80.
Universe Pharmaceuticals Trading Up 10.5 %
The firm’s 50-day moving average price is $4.38 and its two-hundred day moving average price is $50.00.
Institutional Investors Weigh In On Universe Pharmaceuticals
An institutional investor recently bought a new position in Universe Pharmaceuticals stock. Anson Funds Management LP bought a new position in shares of Universe Pharmaceuticals INC (NYSE:UPC – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 230,407 shares of the company’s stock, valued at approximately $141,000. Anson Funds Management LP owned approximately 13.40% of Universe Pharmaceuticals as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 0.18% of the company’s stock.
Universe Pharmaceuticals Company Profile
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.
Further Reading
- Five stocks we like better than Universe Pharmaceuticals
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Short Sellers Gave Up on These 3 Names Recently
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Boring Stocks Outperforming the Market This Year
- What is a SEC Filing?
- If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
Receive News & Ratings for Universe Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universe Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.